DC

Doug Cole

Managing Partner at Flagship Pioneering

Cambridge, Massachusetts

VC
Investor

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Start-up Ventures
Venture Capital
Entrepreneurship
Biotechnology
Drug Discovery
Drug Development
Lifesciences
Medical Devices
Medicine
Medical Diagnostics

Education

Lists including Doug

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Harbinger Health

Series A

Total Funding: $190M

Empress Therapeutics

Series Unknown

Total Funding: $50M

Vesalius Therapeutics

Series A

Total Funding: $75M

Repertoire Immune Medicines

Series A

Total Funding: $210M

Sigilon Therapeutics

Series B

Total Funding: $80M

Foghorn Therapeutics

Series Unknown

Total Funding: $50M

YourBio Health

Series A

Total Funding: $41M

Denali Therapeutics

Series A

Total Funding: $350M

Selecta Biosciences

Seed

Total Funding: $150M

Editas Medicine

Series A

Total Funding: $160M

Work Experience

FP
Flagship Pioneering

2001

  • Managing Partner

    2001

VP
Vertex Pharmaceuticals

1997 - 2001

  • Program Executive

    1997 - 2001

Cytotherapeutics, Inc.

1996 - 1997

  • Medical Director

    1996 - 1997

MG
Massachusetts General Hospital

1987 - 1996

  • Assistant in Neurology

    1992 - 1996

  • Fellow in Neurology

    1990 - 1992

  • Resident in Neurology

    1987 - 1990

HM
Harvard Medical School

1992 - 1996

  • Instructor in Neurology

    1992 - 1996

JH
Johns Hopkins Hospital

1986 - 1987

  • Intern in Internal Medicine, Osler Medical Service

    1986 - 1987